Sandeep Singhal Consultant Clinical Oncologist Newcastle

Sandeep Singhal Consultant Clinical Oncologist Newcastle: Expert in Lung and Gynaecological Cancers

Sandeep Singhal Consultant Clinical Oncologist Newcastle leads cancer care at the Freeman Hospital’s Northern Centre for Cancer Care. He specializes in lung and gynaecological cancers, providing advanced treatments tailored to each patient’s needs. With decades of experience, Dr. Singhal brings expert knowledge and compassion to his work.

Comprehensive Training and Early Career of Sandeep Singhal Consultant Clinical Oncologist Newcastle

Dr. Singhal completed his specialist training in Clinical Oncology at Devi Ahilya University, Indore, and the All India Institute of Medical Sciences, New Delhi in 1991. After that, he served as a Consultant Clinical Oncologist at Gujarat Cancer and Research Institute in Ahmedabad from 1991 to 2004. During this period, he gained extensive experience in treating various cancer types.

Career Development and Recognition

In October 2003, Dr. Singhal earned his Certificate of Completion of Specialist Training (CCST) from The Royal College of Radiologists. He then worked as a Consultant Clinical Oncologist at North Cumbria University Hospitals NHS Trust in Carlisle from 2004 until he joined the Northern Centre for Cancer Care in August 2013.

Research and Special Interests of Sandeep Singhal Consultant Clinical Oncologist Newcastle

Currently, Dr. Singhal plays a vital role in multiple multi-centre research trials focusing on lung and gynaecological malignancies. He is a core member of the Regional Gynaecological Multidisciplinary Team (MDT) at Queen Elizabeth Hospital, Gateshead. Moreover, he has a special interest in Image Guided Adaptive Gynae Brachytherapy, advancing treatment options for patients.

Professional Memberships and Contributions

Dr. Singhal holds membership in prominent organizations such as ASTRO and is a life member of the Union for International Cancer Control (UICC). His active involvement in these groups keeps him at the forefront of oncology developments worldwide.